Brazilian Rare Earths Strengthens Strategic Position After Alurion IPO Success
Brazilian Rare Earths Limited (ASX: BRE) announced that the initial public offering (IPO) of Alurion Resources achieved its maximum subscription target, raising AU$50 million through the issue of 47.6 million shares at AU$1.05 each. Investor demand exceeded the offer size, while Alurion’s directors and management invested more than AU$4.5 million, reflecting strong confidence in the company’s future. Following the IPO, Alurion will have an implied equity valuation of approximately AU$256 million. Brazilian Rare Earths will retain a strategic 16% stake, comprising 39.0 million shares, valued at around AU$41 million at the IPO price. The company also confirmed that Alurion is expected to list on the ASX under the ticker ALU, subject to regulatory approval.
The successful capital raise provides Alurion with funding to accelerate a two-year development program for the Amargosa Bauxite-Gallium Project, including land acquisition, permitting, environmental initiatives and exploration activities. Brazilian Rare Earths stated that the demerger allows it to sharpen its focus on advancing its core rare earth and critical minerals portfolio, with the Monte Alto Scoping Study expected to be the company's next key milestone in August 2026. The indicative timetable targets Alurion’s ASX admission on 30 July 2026 and normal trading from 3 August 2026.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Brazilian Rare Earths Strengthens Strategic Position After Alurion IPO Success
Brazilian Rare Earths Limited (ASX: BRE) announced that the initial public offering (IPO) of Alurion Resources achieved its maximum subscription target, raising AU$50 million through the issue of 47.6 million shares at AU$1.05 each. Investor demand exceeded the offer size, while Alurion’s directors and management invested more than AU$4.5 million, reflecting strong confidence in the company’s future. Following the IPO, Alurion will have an implied equity valuation of approximately AU$256 million. Brazilian Rare Earths will retain a strategic 16% stake, comprising 39.0 million shares, valued at around AU$41 million at the IPO price. The company also confirmed that Alurion is expected to list on the ASX under the ticker ALU, subject to regulatory approval.
The successful capital raise provides Alurion with funding to accelerate a two-year development program for the Amargosa Bauxite-Gallium Project, including land acquisition, permitting, environmental initiatives and exploration activities. Brazilian Rare Earths stated that the demerger allows it to sharpen its focus on advancing its core rare earth and critical minerals portfolio, with the Monte Alto Scoping Study expected to be the company's next key milestone in August 2026. The indicative timetable targets Alurion’s ASX admission on 30 July 2026 and normal trading from 3 August 2026.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au